Background Silicosis is an important occupational disease caused by inhalation of free silica
and is characterized by persistent pulmonary inflammation, subsequent fibrosis and lung …

Silicosis is an occupational lung disease caused by inhaling silica dust. The disease is
characterized by early lung inflammation and late irreversible pulmonary fibrosis. Here we …

Background Silicosis is a severe pulmonary disease caused by inhaling dust containing
crystalline silica. The progression of silicosis to pulmonary fibrosis is usually unavoidable …

Background: To study the protective effect of Cordyceps sinensis extract (Dong Chong Xia
Cao in Chinese [DCXC]) on experimental acute lung injury (ALI) mice. Methods and results …

Abstract Background Yangqing Chenfei formula (YCF) is a traditional Chinese medicine
formula for early-stage silicosis. However, the therapeutic mechanism is unclear. The …

Abstract Background Yangqing Chenfei formula (YCF) has been demonstrated its clinical
efficiency on silicosis patients. However, the effect of YCF against silicotic fibrosis and its …

Silicosis is one of the most prevalent chronic occupational pulmonary diseases worldwide.
The present study aimed to investigate the effects of methyl palmitate on silica-induced lung …

Background Inhalation of dust containing silica particles is associated with severe
pulmonary inflammation and lung injury leading to chronic silicosis including fibrotic …

Silicosis is a fatal fibrotic lung disease caused by long-term silica particle exposure, in which
pulmonary macrophages play an important role. However, the relationship between …

PA-824 is a novel bicyclic nitroimidazole anti-tuberculosis (TB) drug. Cordyceps sinensis
(Berk.) Sacc.(CS) was proven to be a good immunomodulatory compound. This research …